Marubeni: [Updated] Summary of Consolidated Financial Results For the Nine-Month Period Ended December 31, 2024 (IFRS basis)

Feb 10 15:30

Marubeni: Summary of financial results for the 3rd quarter of the fiscal year ending March 31, 2025 (completion of mid-term review by an audit firm)

Feb 10 15:30

Change report.

Feb 10 15:01

Marubeni: Notice Regarding Share Repurchases

Feb 5 10:00

Marubeni: Notice Regarding the Revision of the Dividend Forecast for the Fiscal Year Ending March 31, 2025

Feb 5 10:00

Marubeni: Summary of Consolidated Financial Results For the Nine-Month Period Ended December 31, 2024 (IFRS basis)

Feb 5 10:00

Marubeni: Medium-Term Management Strategy (2025-2027) GC2027

Feb 5 10:00

Marubeni: Mid-Term Management Strategy(FYE 3/2026-FYE 3/2028) GC2027

Feb 5 10:00

Marubeni: Notice Concerning Decisions on Matters Relating to Repurchase of Own Shares

Feb 5 10:00

Marubeni: Notice regarding revisions to dividend forecasts for the fiscal year ending March 31, 2025

Feb 5 10:00

Marubeni: Summary of financial results for the 3rd quarter of the fiscal year ending 2025/3 [IFRS] (consolidated)

Feb 5 10:00

Marubeni: Corrected Issuance Registration Form

Dec 20, 2024 14:18

Marubeni: Interim report.

Dec 20, 2024 14:03

Marubeni: Changes in representative directors, executive personnel, and organizational reforms

Dec 18, 2024 15:00

Marubeni: (Correction) Partial Corrections to the “Notice Concerning Policy Decisions on Equity Transfer Involving Transfer of Specific Subsidiaries”

Nov 29, 2024 13:30

Marubeni: Correction Issuance Registration Form

Nov 29, 2024 10:38

Marubeni: Extraordinary Report

Nov 29, 2024 09:06

Marubeni: Announcement of the Decision on an Equity Transfer of a Specified Subsidiary

Nov 29, 2024 09:00

Marubeni: Notice regarding policy decisions on equity transfers involving changes in specific subsidiaries

Nov 29, 2024 09:00

Marubeni: Change of Chairman, and President and CEO

Nov 27, 2024 15:00